Therefore, albeit not yet reported in patients with HNSCC treated with immunotherapy, it is not surprising that our patients with higher TGF-β levels (above the threshold of 336.85 pg/mL) exhibited a poor OS. Here, TGFB1 is linked to head and neck squamous cell carcinoma.